These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7625884)

  • 1. Comparative vasodepressor effects of 3-pyridine derivatives possessing the cyanoamidine or amide structure in pithed rats.
    Kashiwabara T; Nakajima T; Hasegawa S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 328(3):297-306. PubMed ID: 7625884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo K channel-opening effects of Ki3315, a metabolite of the novel vasodilator KRN2391.
    Tanaka Y; Okada Y; Yokoyama T; Nakajima T; Izawa T; Fukushima H; Ogawa N
    Arch Int Pharmacodyn Ther; 1993; 326():62-71. PubMed ID: 8185414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide.
    Ogawa N; Fukata Y; Kaneta S; Jinno Y; Fukushima H; Nishikori K
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):11-7. PubMed ID: 1383619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological analysis of the vasodepressor effect of KRN2391 in pithed rats.
    Tanaka Y; Yokoyama T; Kashiwabara T; Fukushima H; Izawa T; Ogawa N
    Gen Pharmacol; 1993 Nov; 24(6):1379-81. PubMed ID: 8112509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.
    Harada K; Miwa A; Kaneta S; Izawa T; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):679-84. PubMed ID: 7689399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs.
    Ogawa N; Jinno Y; Kaneta S; Harada K; Fukata Y; Fukushima H
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):874-82. PubMed ID: 7687711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cardiovascular effects of KRN2391 and other coronary vasodilators in anesthetized open-chest dogs.
    Ogawa N; Kaneta S; Jinno Y; Kasai H; Nishikori K; Fukushima H
    Arch Int Pharmacodyn Ther; 1992; 318():36-46. PubMed ID: 1463370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
    Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation by KRN2391 and nicorandil of glibenclamide-sensitive K+ channels in Xenopus oocytes.
    Sakuta H; Okamoto K
    Eur J Pharmacol; 1993 Feb; 244(3):277-83. PubMed ID: 8458402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim.
    Saito K; Sakai K
    Fundam Clin Pharmacol; 1998; 12(1):37-43. PubMed ID: 9523182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo vasodilating effects of KRN4884, Ki1769 and Ki3005, pyridinecarboxamidine derivatives.
    Izumi H; Kawahara J; Takeuchi A; Izawa T; Ogawa N
    Fundam Clin Pharmacol; 1997; 11(6):561-6. PubMed ID: 9444524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
    Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of KRN2391 in canine coronary vascular bed.
    Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
    Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
    Cavero I; Pratz J; Mondot S
    Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
    Borg C; Mondot S; Mestre M; Cavero I
    J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiating effect of nicorandil on the adenosine A2 receptor-mediated vasodepression in rats: potential role for KATP channels.
    Saito K; Sakai K
    Fundam Clin Pharmacol; 1998; 12(2):143-51. PubMed ID: 9565767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats.
    Harada K; Fukata Y; Miwa A; Kaneta S; Fukushima H; Ogawa N
    Jpn J Pharmacol; 1993 Sep; 63(1):35-9. PubMed ID: 8271529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of hypotension induced by KRN2391 and nicardipine in isoflurane anaesthetized dogs.
    Takeda S; Ozawa Y; Tomaru T
    Can J Anaesth; 1997 Sep; 44(9):1002-7. PubMed ID: 9305565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of nicorandil on the vasodepressor responses to vasoactive polypeptides administered intravenously to rats.
    Sakai K; Akima M; Saito K
    J Pharm Pharmacol; 1998 Feb; 50(2):211-4. PubMed ID: 9530990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.